MAP3K7 Antikörper
Kurzübersicht für MAP3K7 Antikörper (ABIN7605490)
Target
Alle MAP3K7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Anti-MAP3K7 Monoclonal Antibody
-
Produktmerkmale
- Anti-MAP3K7 Monoclonal Antibody (ABIN7605490). Tested in WB, IHC, ICC/IF, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat.
-
Aufreinigung
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from human MAP3K7
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:500-1:2000
IHC 1:50-1:200
ICC/IF 1:100-1:500
FC 1:50 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Restore with deionized water (or equivalent) for reconstitution volume of 1.0 mL
-
Konzentration
- Lot specific
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.
-
-
- MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7))
-
Andere Bezeichnung
- MAP3K7
-
Hintergrund
-
Synonyms: Cathepsin B,3.4.22.1,APP secretase,APPS,Cathepsin B1,Cathepsin B light chain,Cathepsin B heavy chain,CTSB,CPSB,
Tissue Specificity: Found on monocytes, neutrophils and eosinophil platelets.
-
Molekulargewicht
- 75 kDa
-
UniProt
- O43318
-
Pathways
- NF-kappaB Signalweg, T-Zell Rezeptor Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Toll-Like Receptors Cascades, BCR Signaling, Ubiquitin Proteasome Pathway
Target
-